top of page


  • Methods and compositions for use of neutrophil elastase and proteinase 3 as diagnostic biomarkers (WIPO (PCT) number: WO2015180687A1)

  • Methods and Compositions for use of Neutrophil Elastase and Proteinase 3 as Diagnostic Markers (US patent number: US9625460B2).

  • Non-polyaminated lcn2 as a biomarker for diagnosis and treatment of cardiometabolic diseases (WIPO (PCT) number: WO2018076284A1)

  • Inhibitors of fabp4 and methods of treating arthritis (WIPO (PCT) number: WO2018192469A1)

  • Lipocalin-2 antibodies for methods of treatments. (US patent number: 8,481,032B2)

  • Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks. (US patent number: 8,030,097 B2)

  • Phosphoprotein target for insulin and insulin antagonists. (US patent number: US 6,884,575)

  • Adiponectin and uses thereof. (US patent Number: 7,365,170)

  • Lipocalin-2 as a diagnostic marker and therapeutic target. (US patent No: 7,645,616.)

bottom of page